Disorders

Overall I learned a great deal during my hospital adventure. The whole experience seemed like a comedy of errors. For me the only people there who were truly out of touch with reality were staff members. All of the patients were very present, albeit in some distress. The reasons for their distress were not unreasonable.

A new article suggests counselors and psychotherapists are dissatisfied with current diagnostic systems and outlines some potential alternatives.

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

The writings of Pies and his colleagues, I believe, provide a compelling case study of cognitive dissonance. Cognitive dissonance arises when people are presented with information that creates conflicted psychological states, challenging some belief they hold dear, and people typically resolve dissonant states by sifting through information in ways that protect their self-esteem and their financial interests. It is easy to see that process operating here.

TMS is a psychiatric treatment that uses a rapidly alternating magnetic field to induce electric currents in the brain. These currents stimulate neurons, causing them to "fire." When used repetitively, TMS is said to alter the excitability of the brain area that has been stimulated. In the psychiatric field, TMS is being used increasingly as a treatment for depression, particularly with so-called treatment-resistant clients. I Googled the string "TMS + depression" and got 1.35 million hits. So the idea is attracting attention.

This review of the scientific literature, stretching across six decades, makes the case that antipsychotics, over the long-term, do more harm than good. The drugs lower recovery rates and worsen functional outcomes over longer periods of time.

What if we don't have a depression epidemic, but a stress epidemic of traumatic proportions? What if we've been steered away from learning how our minds and bodies actually work, and into believing that our attempts to survive traumatic, threatening real-life circumstances are "symptoms of mental illness"?

The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”

In just two decades, pointing out the pseudoscience of the DSM has gone from being an “extremist slur of radical anti-psychiatrists” to a mainstream proposition from the former chairs of both the DSM-3 and DSM-4 taskforces and the director of NIMH. In addition to the pathologizing of normal behaviors, another explanation for the epidemic — the adverse effects of psychiatric medications — is also evolving from radical to mainstream, thanks primarily to the efforts of Robert Whitaker and his book Anatomy of an Epidemic. While diagnostic expansionism and Big Pharma certainly deserve a large share of the blame for this epidemic, there is another reason.

For years I had hoped that psychiatry would free itself from the psychoanalytic doctrine, and when my wish finally came true, my profession went from the frying pan to the fire. My main goal, currently, is to convince professionals as well as the public that most child psychiatric problems can be handled effectively without medication.

A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.

While a great deal of the excitement about advances in psychological treatments comes from the potential for research in neuroscience to unlock the secrets of the brain, many mental health experts would like to temper this enthusiasm. A special issue of the Behavior Therapist released this month calls into question the predominant conception of mental illnesses as brain disorders.

A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.

A new study published in Frontiers in Psychiatry concludes that “antidepressants are largely ineffective and potentially harmful.”

Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.

Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.

My life flashed before my eyes as my entire medical history over the last decade was rewritten from having a genetic brain disease to being a victim of a medical scam. It was bittersweet, for I realized that I was not sick and dying, but I had been robbed of so many years of my life due to the psychiatrist’s lies. Now I am suing my former psychiatrist for damages.

While increasing numbers of Americans are being prescribed antidepressants, the Centers for Disease Control reports that suicide rates increased 28% from 1999 to 2010. Trained professionals remain unable to predict who is at risk. Their guess is as good as chance.

Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

What Dr. Frances calls "massive mislabeling" is not the assignment of psychiatry's spurious labels as such, but rather what he calls the overuse of these labels. This notion of conservative, careful and accurate diagnosis is a common theme in Dr. Frances's writing, but in fact, it's an empty exhortation, because the criteria are inherently vague and ill-defined.

It now looks as if the U.S. approach to mental health is fast gaining purchase in a country that formerly boasted a great, perhaps too sophisticated (Lacan et al.) psychoanalytic tradition, but also a holistic psychosocial tradition when dealing with psychological disturbance in children.

To help my non-recovery oriented colleagues understand the stigma/resentment associated with ‘borderline personality disorder,’ I simply mention this: “Let’s say I call you and say, ‘Hey, I’ve got a referral for you. She’s been diagnosed with borderline personality disorder . . .’” I need to go no further; without fail, my colleague will smile or laugh. We both know that such a referral is a no-no, so much so that it doesn’t even have to be mentioned; it is a given.

Results from a 30-year prospective study demonstrated worse outcomes for people who took antidepressants, even after controlling for gender, education level, marriage, baseline severity, other affective disorders, suicidality, and family history of depression.

The use of machine learning algorithms (known as artificial intelligence) in the medical field raises a slew of ethical concerns.